Hologic Statement on Recently Released USPSTF Breast Cancer Screening Guidelines

May 10, 2023 — Hologic has issued a statement in reaction to the proposed USPSTF guidelines. As a leader in women’s health, Hologic understands the importance of breast cancer screenings and commends the USPSTF for changing their draft guidelines to recommend that women begin screening at age 40. 

The statement reads: “We commend the USPSTF for changing their draft guidelines to recommend that women begin screening at 40. Lowering the age for initial screening to 40 is critical as approximately 60,000 breast cancers are diagnosed each year in women under 50. Further, Black women are more likely to develop aggressive cancers at younger ages than white women and are 40 percent more likely to die from breast cancer than white women.   

“The draft guidelines issued today are a significant step forward for women, narrowing the gap between USPSTF guidelines and those of leading professional societies and current clinical best practices. Hologic is committed to working with the Task Force and others in the breast cancer community in support of final guidelines that promote early detection, improve treatment options and reduce health inequities.” 

You can review the proposed guidelines here. 

For more information: www.hologic.com 

Related Breast Density Content: 

VIDEO: Research and Advancements in Breast Imaging Technology 

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule 

One on One … with Wendie Berg, MD, PhD, FACR, FSBI 

Creating Patient Equity: A Breast Density Legislative Update 

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public 

AI Provides Accurate Breast Density Classification 

VIDEO: The Impact of Breast Density Technology and Legislation 

VIDEO: Personalized Breast Screening and Breast Density 

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference 

Fake News: Having Dense Breast Tissue is No Big Deal 

The Manic World of Social Media and Breast Cancer: Gratitude and Grief 

Related Breast Imaging Content: 

Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis 

Today's Mammography Advancements  

Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings  

AI DBT Impact on Mammography Post-breast Therapy  

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI  

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs  

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography 

Study Finds Racial Disparities in Access to New Mammography Technology 

American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation